Citigroup (C)
143.78
+0.79 (0.55%)
NYSE· Last Trade: Jun 17th, 4:55 PM EDT
AppLovin's stock is down this year, but Wall Street analysts remain bullish.
Via The Motley Fool · June 17, 2026
Portfolio concentration and index strategy set these two banking ETFs apart for investors seeking sector exposure.
Via The Motley Fool · June 16, 2026
Several high-profile IPOs are boosting investment banking stocks.
Via The Motley Fool · June 16, 2026
Buybacks signal executive confidence in business and cash flow and provide leverage for investors that builds over time.
Via MarketBeat · June 15, 2026
Could this unloved altcoin finally stabilize in the second half of 2026?
Via The Motley Fool · June 15, 2026
What Happened? Shares of freight delivery company Knight-Swift Transportation (NYSE:KNX) fell 2.9% in the morning session after Citigroup downgraded the stoc...
Via StockStory · June 15, 2026
Top Wall Street analysts changed their outlook on top names. See all rating changes on our analyst ratings page. Barclays, Wells Fargo, Piper Sandler, Leerink Partners, Truist Securities, and Citigroup updated their price targets and ratings for AVA, LEN, GMED, SABS, PDM, and PAYX. Evercore ISI Group and Truist Securities also raised their price targets and ratings for LEN and DDOG.
Via Benzinga · June 15, 2026
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the consumer discretionary - apparel and accessories stocks, including Carter's (NYSE:C...
Via StockStory · June 14, 2026
Agentic AI will be a powerful growth driver.
Via The Motley Fool · June 12, 2026
Investors looking for AI plays in the stock market probably wouldn't look at industrial manufacturers -- but there are some hidden gems for the savvy.
Via The Motley Fool · June 11, 2026
One of this year's hottest artificial intelligence IPOs has become a top pick among analysts.
Via The Motley Fool · June 11, 2026
Wall Street reassessed tech leadership as Apple’s AI reveal underwhelmed and yesterday's AI recovery unwound, today, June 9, 2026.
Via The Motley Fool · June 9, 2026
Zealand Pharma's stock is cratering today after disappointing results from a late-stage trial of its GLP-1 dual-receptor agonist drug.
Via The Motley Fool · June 8, 2026
It flipped into the black on the bottom line in its latest reported quarter.
Via The Motley Fool · June 8, 2026
The SpaceX IPO is going to be huge, but no one knows what the stock will do once it's public.
Via The Motley Fool · June 7, 2026
The stock market appears to be rotating into health care.
Via Investor's Business Daily · June 6, 2026

As the month rolled on, investors grew less enthused about the idea of powering their portfolios with this nuclear fuel specialist.
Via The Motley Fool · June 5, 2026
Banks use their capital and expertise to help businesses grow while offering consumers essential financial products like mortgages and credit cards. Still, i...
Via StockStory · June 5, 2026
UBS and Citigroup stocks are both close to emerging from cup bases. The two stocks advanced on Thursday.
Via Investor's Business Daily · June 4, 2026
Explore how global diversification and lower costs impact risk and income for financial sector ETF investors seeking more than just U.S. bank exposure.
Via The Motley Fool · June 4, 2026
Looking back on diversified banks stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Truist Financial (NYSE:TFC) and its pee...
Via StockStory · June 3, 2026
ChargePoint (CHPT) Q1 2027 Earnings Transcript
Via The Motley Fool · June 3, 2026
There is a new twist this year with the Fed's stress tests.
Via The Motley Fool · June 3, 2026
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements...
Via StockStory · June 3, 2026
Kohl's delivered its strongest comparable sales performance in four years, but investors still have reason to be cautious about the retailer.
Via MarketBeat · June 2, 2026